Strategy

Regulatory T cells to be tested in liver transplants

The next direction for Alzheimer's disease treatments

A new start for an amyloidosis therapy

Novel antifungals set for market introduction

Covid-19 and the future of diagnostics

A new strategy for regenerating damaged tissue

Leyden Labs plans to protect against viral infections

How exchange traded funds could benefit Europe

New technologies boost drug repurposing

The Bispecific Approach, Interviews with Merus, Genmab and NovalGen